Delivery Order SPE2DB22D3301-SPE2DB25FY8BR
- Not listed
- The Defense Logistics Agency awarded a $812.58 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200mg Trokendi XR capsules. Under this order, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania by July 17, 2023 to support the Department of Defense's medical supply needs. As a top pharmaceutical supplier, Amerisourcebergen routinely fulfills delivery orders under the Defense Logistics Agency's prime vendor contracts to provide...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $488.82 to Amerisourcebergen Drug Corporation for the supply of 100mg Trokendi XR capsules. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 30 capsules to a location in Conshohocken, Pennsylvania under a one-day period of performance from August 28 to 29, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to support the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $463 to Amerisourcebergen Drug Corporation for the supply of 100mg Trokendi XR capsules. As the prime contractor, Amerisourcebergen Drug Corporation will deliver 30 capsules to an address in Conshohocken, Pennsylvania under a one day period of performance from August 30th to August 31st, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution contracts to...
- This is a $1,084.82 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of Trokendi XR 100 mg capsules to support DLA Troop Support Medical programs. AmerisourceBergen Drug Corp, through its Corporate Office division, regularly provides pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense. This delivery order...
- The Defense Logistics Agency awarded a $2,423 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg capsules of Trokendi XR. As the prime contractor, Amerisourcebergen will deliver 30 capsules to a facility in Conshohocken, Pennsylvania, completing performance within a day of the September 26, 2023 start date. The parent company, Amerisourcebergen Corporation, received the award utilizing its corporate office and distribution division. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $751.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg Trokendi XR capsules. Under this order, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania by July 28, 2023 to fulfill requirements on behalf of the Department of Defense. As a top pharmaceutical supplier, Amerisourcebergen routinely supports the DLA's medical materiel needs through existing indefinite delivery vehicle contracts. No...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $813.73 to Amerisourcebergen Drug Corp for the supply of 100mg Trokendi XR capsules. Under this single award, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania, with performance required between August 1st and 2nd, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen routinely supports the Agency's medical readiness and logistics programs...
- This federal contract award, valued at $3,640.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 100 mg capsules, a medication used to treat certain neurological conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,450.26, is for the delivery of Trokendi XR 50 mg capsules. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
- This is a $1,021.88 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trokendi XR 100 mg capsules, a specialty medication, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8BRDelivery Order
The Defense Logistics Agency awarded a $29,860.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units). The award was made without a set-aside designation through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order represents a child contract action under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical supply vehicle valued through December 2026. As a critical vendor in the federal medical supply chain, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. Trokendi XR, an anticonvulsant medication, supports the Defense Health Agency and other federal healthcare programs' therapeutic requirements. The delivery order is scheduled for completion by July 21, 2025, reflecting the expedited nature of pharmaceutical procurement under the Defense Logistics Agency's medical supply operations. This award demonstrates AmerisourceBergen Drug Corp's continued role as a primary distributor for federal pharmaceutical needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.9k | 7/18/25 |